FDA Claims Popular Eyelash Growth Product is a Drug, Not a Cosmetic
The FDA sent a letter to Allergan expressing concerns that the eyelash growth drug Latisse is being incorrectly promoted as a cosmetic product. The active ingredient, bimatoprost, clearly affects the structure and function of the body and is therefore not a cosmetic, according to the FDA definition of a cosmetic product. Interestingly, Allergan had been …
FDA Claims Popular Eyelash Growth Product is a Drug, Not a Cosmetic Read More »